Fig. 1: The clinical significance of FAAH and GPX4 in advanced ccRCC. | Cell Death & Disease

Fig. 1: The clinical significance of FAAH and GPX4 in advanced ccRCC.

From: Combination treatment with FAAH inhibitors/URB597 and ferroptosis inducers significantly decreases the growth and metastasis of renal cell carcinoma cells via the PI3K-AKT signaling pathway

Fig. 1: The clinical significance of FAAH and GPX4 in advanced ccRCC.The alternative text for this image may have been generated using AI.

Quantitative polymerase chain reaction was used to detect the expression of FAAH and GPX4 in clinical specimens from ccRCC patients. (A, B) Patients were divided into two groups (high-expression group or low-expression group) according to their median expression of GPX4 (A) and FAAH (B). The results are displayed as scatter plots and histograms. Clinical analysis was performed based on follow-up data from patients (C, D). The prognosis of patients (overall survival) in the high/low groups of GPX4 (C) or high/low groups of FAAH (D) is shown as a survival curve. *P < 0.05.

Back to article page